HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells
- PMID: 36835344
- PMCID: PMC9959463
- DOI: 10.3390/ijms24043933
HSPs/STAT3 Interplay Sustains DDR and Promotes Cytokine Release by Primary Effusion Lymphoma Cells
Abstract
Primary effusion lymphoma (PEL) is a rare and aggressive B-cell lymphoma, against which current therapies usually fail. In the present study, we show that targeting HSPs, such as HSP27, HSP70 and HSP90, could be an efficient strategy to reduce PEL cell survival, as it induces strong DNA damage, which correlated with an impairment of DDR. Moreover, as HSP27, HSP70 and HSP90 cross talk with STAT3, their inhibition results in STAT3 de-phosphorylation and. On the other hand, the inhibition of STAT3 may downregulate these HSPs. These findings suggest that targeting HSPs has important implications in cancer therapy, as it can reduce the release of cytokines by PEL cells, which, besides affecting their own survival, could negatively influence anti-cancer immune response.
Keywords: DDR; HSP27; HSP70; HSP90; PEL; STAT3; cytokines.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.Eur Urol. 2014 Jul;66(1):145-55. doi: 10.1016/j.eururo.2013.12.019. Epub 2013 Dec 29. Eur Urol. 2014. PMID: 24411988 Free PMC article.
-
Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27.Prion. 2007 Jan-Mar;1(1):53-60. doi: 10.4161/pri.1.1.4059. Epub 2007 Jan 24. Prion. 2007. PMID: 19164900 Free PMC article. Review.
-
Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva.Mol Vis. 2014 Mar 30;20:441-57. eCollection 2014. Mol Vis. 2014. PMID: 24715760 Free PMC article.
-
The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.Biol Pharm Bull. 2012;35(5):725-30. doi: 10.1248/bpb.35.725. Biol Pharm Bull. 2012. PMID: 22687408
-
HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).Int J Oncol. 2014 Jul;45(1):18-30. doi: 10.3892/ijo.2014.2399. Epub 2014 Apr 25. Int J Oncol. 2014. PMID: 24789222 Review.
Cited by
-
Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53.Biology (Basel). 2024 Jul 8;13(7):508. doi: 10.3390/biology13070508. Biology (Basel). 2024. PMID: 39056701 Free PMC article. Review.
-
HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets.Cancers (Basel). 2023 Nov 29;15(23):5651. doi: 10.3390/cancers15235651. Cancers (Basel). 2023. PMID: 38067355 Free PMC article.
-
NFE2L2 and STAT3 Converge on Common Targets to Promote Survival of Primary Lymphoma Cells.Int J Mol Sci. 2023 Jul 18;24(14):11598. doi: 10.3390/ijms241411598. Int J Mol Sci. 2023. PMID: 37511362 Free PMC article.
-
Mutant p53 upregulates HDAC6 to resist ER stress and facilitates Ku70 deacetylation, which prevents its degradation and mitigates DNA damage in colon cancer cells.Cell Death Discov. 2025 Apr 10;11(1):162. doi: 10.1038/s41420-025-02433-9. Cell Death Discov. 2025. PMID: 40210861 Free PMC article.
-
Conserved mechanisms of self-renewal and pluripotency in mouse and human ESCs regulated by simulated microgravity using a 3D clinostat.Cell Death Discov. 2024 Feb 9;10(1):68. doi: 10.1038/s41420-024-01846-2. Cell Death Discov. 2024. PMID: 38336777 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous